data_1oy2_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1oy2 _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.21 0 N-CA-C 112.447 -0.261 . . . . 0.0 112.447 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 19.9 mt-30 63.13 158.06 0.07 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.753 0.311 . . . . 0.0 110.892 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -130.13 115.42 17.02 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.922 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 89.93 162.22 38.15 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.368 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -143.87 -177.18 18.56 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.57 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -166.7 37.04 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.754 0.311 . . . . 0.0 110.925 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -106.33 27.93 8.24 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.968 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -102.99 163.82 11.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.897 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -152.59 60.52 0.81 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.005 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -131.95 28.48 4.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.851 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 13.7 m-70 -100.88 165.29 11.42 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.979 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -75.32 -179.61 44.4 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.497 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -86.52 -163.47 0.9 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.764 0.316 . . . . 0.0 110.906 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -72.27 172.74 9.74 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.982 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.2 m -49.61 -58.82 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.346 -179.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.421 ' OD1' ' N ' ' A' ' 32' ' ' ASN . 5.3 p-10 170.1 66.19 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.809 0.338 . . . . 0.0 110.875 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.2 mttm -149.48 137.51 11.75 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.907 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -78.25 170.48 18.53 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.587 2.191 . . . . 0.0 112.386 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.6 t -168.32 167.84 11.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.948 179.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -141.97 128.93 20.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.978 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -123.72 -142.64 6.09 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.345 179.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . 0.489 ' CE2' HG23 ' A' ' 126' ' ' VAL . 17.0 t-105 -62.83 136.76 58.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.735 0.302 . . . . 0.0 111.005 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.2 tp 67.88 -62.45 0.35 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.751 -179.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . 0.527 ' CB ' ' HD3' ' A' ' 41' ' ' PRO . 36.5 m-70 -151.71 -81.87 0.01 OUTLIER Pre-proline 0 CA--C 1.539 0.555 0 CA-C-O 119.202 -0.427 . . . . 0.0 111.511 179.128 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.527 ' HD3' ' CB ' ' A' ' 40' ' ' HIS . 23.3 Cg_endo -89.3 -175.76 1.18 Allowed 'Trans proline' 0 C--N 1.359 1.102 0 C-N-CA 121.58 1.52 . . . . 0.0 112.356 179.435 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.425 ' O ' ' CG2' ' A' ' 45' ' ' VAL . 1.1 m-20 -90.67 -36.55 14.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.366 177.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -62.31 -25.54 67.93 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.258 -179.698 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.423 ' O ' ' N ' ' A' ' 49' ' ' GLY . 2.1 tppm? -59.52 -27.89 66.58 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.339 -179.232 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.425 ' CG2' ' O ' ' A' ' 42' ' ' ASN . 1.1 m -95.58 -40.0 10.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.691 0.281 . . . . 0.0 111.454 179.339 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' MET . . . . . 0.435 ' HG2' ' CG2' ' A' ' 128' ' ' THR . 14.6 mtm -78.15 0.98 22.8 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -178.522 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -132.32 -74.25 0.1 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.032 -1.08 . . . . 0.0 113.24 -179.131 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -85.29 -35.72 0.15 Allowed 'Trans proline' 0 N--CA 1.462 -0.327 0 C-N-CA 122.899 2.399 . . . . 0.0 113.22 -177.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.423 ' N ' ' O ' ' A' ' 44' ' ' LYS . . . 73.32 138.86 0.37 Allowed Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.123 -178.685 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.445 ' CG2' ' CG2' ' A' ' 126' ' ' VAL . 3.8 m -81.97 114.14 22.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.777 0.323 . . . . 0.0 110.817 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 91.3 p -128.58 130.12 46.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.029 0.442 . . . . 0.0 111.824 -178.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.495 ' CD1' ' HB2' ' A' ' 186' ' ' LEU . 0.3 OUTLIER -152.01 178.37 9.51 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.124 178.606 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 8.4 mt -88.18 106.87 18.48 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.067 0.46 . . . . 0.0 110.759 179.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.454 ' CG2' ' CB ' ' A' ' 124' ' ' LEU . 0.2 OUTLIER -126.57 136.25 61.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.713 179.872 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.36 113.69 20.31 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.084 0.469 . . . . 0.0 110.912 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 45.0 t80 -74.65 116.95 15.93 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.374 179.1 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 0.414 ' HB2' ' CG2' ' A' ' 179' ' ' ILE . 34.0 mmm -103.1 146.06 28.96 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.412 -178.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -43.17 170.46 0.01 OUTLIER Glycine 0 C--N 1.331 0.301 0 CA-C-N 115.624 -0.716 . . . . 0.0 113.51 -178.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 13.7 m -98.01 164.52 12.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.837 0.351 . . . . 0.0 111.038 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.425 ' CG1' ' OG ' ' A' ' 113' ' ' SER . 33.0 m -123.46 116.77 49.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.06 -179.613 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.429 ' CB ' ' O ' ' A' ' 112' ' ' ARG . 16.9 tp10 -77.4 116.99 18.45 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.774 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 6.7 t -108.38 147.47 13.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.268 -179.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -114.47 -24.71 8.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.13 -179.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -45.25 161.39 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.479 -179.543 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -172.97 -68.42 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.806 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 1.7 mtt -113.07 -67.63 0.99 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.719 179.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 34.7 ttm-85 -67.07 82.42 0.12 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.774 179.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -124.66 -163.15 1.14 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.317 -179.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.47 ' CD1' ' NE2' ' A' ' 76' ' ' GLN . 8.1 tt -49.67 -67.75 0.23 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.93 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -171.29 84.48 0.08 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.761 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 51.75 24.92 2.64 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.893 -179.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 16.5 p30 -174.27 151.31 1.61 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.099 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.427 ' HB ' ' CG2' ' A' ' 77' ' ' VAL . 0.0 OUTLIER -168.95 31.24 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.868 179.856 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 2.0 mtp85 -67.17 -65.02 0.74 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.16 -179.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.424 ' OG1' ' N ' ' A' ' 76' ' ' GLN . 0.6 OUTLIER -59.55 -59.9 4.7 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.984 0.421 . . . . 0.0 110.078 179.819 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.493 ' CB ' ' CB ' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -41.63 -67.74 0.23 Allowed 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.359 -179.214 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.427 ' CG2' ' HB ' ' A' ' 73' ' ' THR . 86.8 t -51.13 -69.87 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.462 -178.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 3.4 m -41.6 -29.59 0.18 Allowed 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.754 -178.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 40.9 ttt180 -64.36 -59.11 4.75 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.411 -0.358 . . . . 0.0 110.623 179.132 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.44 ' HB2' ' CD ' ' A' ' 105' ' ' PRO . 2.8 tt0 -65.32 -33.76 76.74 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.87 179.755 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -58.64 -59.75 4.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.922 179.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.418 ' O ' ' CG1' ' A' ' 85' ' ' VAL . 20.7 mt -50.8 -46.86 29.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.754 179.517 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -62.76 -27.59 69.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.385 178.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.41 -61.12 2.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.789 179.61 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.418 ' CG1' ' O ' ' A' ' 82' ' ' ILE . 3.9 p -48.87 -38.5 10.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.824 179.42 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . 0.406 ' N ' HG12 ' A' ' 85' ' ' VAL . 0.0 OUTLIER -67.59 -36.88 81.71 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.793 179.475 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -56.3 -47.67 78.23 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.744 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -67.44 -42.91 82.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.059 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 7.4 p -119.12 78.81 17.78 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.862 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -69.76 -9.87 27.16 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.681 2.254 . . . . 0.0 112.823 -179.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -48.48 -36.95 18.49 Favored Glycine 0 C--N 1.331 0.3 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.554 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -68.25 -36.16 79.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.793 0.33 . . . . 0.0 111.101 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 56.98 102.72 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.843 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -147.35 -45.57 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.725 -179.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -123.74 -44.17 2.1 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.734 0.302 . . . . 0.0 111.245 -179.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 12.2 t -125.48 -164.92 1.35 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.053 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -168.66 140.46 2.69 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.878 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 9.2 mmm180 61.47 -82.65 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.849 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -168.3 129.49 1.34 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.85 179.66 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -179.59 93.23 0.2 Allowed Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.977 -179.377 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -67.52 143.77 64.25 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.587 2.191 . . . . 0.0 112.374 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 20.2 m -126.87 159.86 32.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.017 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 11.6 t -75.56 -177.05 3.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.009 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 13.9 mmm180 60.65 152.6 0.1 OUTLIER Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.901 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.493 ' CB ' ' CB ' ' A' ' 76' ' ' GLN . 60.7 Cg_endo -72.03 -178.01 19.16 Favored 'Cis proline' 0 C--N 1.35 0.627 0 C-N-CA 123.83 -1.321 . . . . 0.0 113.015 0.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 17.1 tp -80.41 157.86 26.14 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.34 -179.109 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.425 ' O ' ' CD1' ' A' ' 109' ' ' ILE . 0.1 OUTLIER 74.83 170.72 0.28 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.097 179.687 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 47.1 t -85.44 88.09 7.47 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.048 -179.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.441 ' CD1' ' HG2' ' A' ' 105' ' ' PRO . 0.2 OUTLIER -125.27 160.31 31.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.054 179.639 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.418 ' CD1' ' HA ' ' A' ' 77' ' ' VAL . 1.7 mp 64.06 157.93 0.08 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.341 179.408 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -133.83 -51.98 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.35 0 CA-C-N 115.916 -0.583 . . . . 0.0 112.075 179.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . 0.429 ' O ' ' CB ' ' A' ' 61' ' ' GLU . 5.3 tmm_? -179.98 138.59 0.12 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.86 0.362 . . . . 0.0 110.915 179.219 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' SER . . . . . 0.425 ' OG ' ' CG1' ' A' ' 60' ' ' VAL . 50.4 m -105.1 140.48 38.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.167 -179.655 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -101.88 133.78 46.12 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.022 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.438 ' O ' ' CD2' ' A' ' 115' ' ' LEU . 0.0 OUTLIER -80.24 4.87 16.22 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.955 -0.566 . . . . 0.0 112.074 -179.462 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -42.06 99.73 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 120.811 0.338 . . . . 0.0 111.499 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 70.95 54.04 0.25 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.69 -179.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -104.82 157.66 17.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.329 -179.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 53.74 37.02 56.26 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.919 -0.657 . . . . 0.0 112.65 179.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -106.97 116.71 58.12 Favored Pre-proline 0 C--N 1.329 -0.31 0 O-C-N 122.932 -0.157 . . . . 0.0 110.58 179.469 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -85.58 109.26 1.1 Allowed 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 122.362 2.041 . . . . 0.0 112.339 178.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.429 ' CG2' ' HA ' ' A' ' 135' ' ' ALA . 2.4 pp -135.91 173.5 13.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.964 179.661 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.417 ' N ' HD11 ' A' ' 122' ' ' ILE . 0.0 OUTLIER -94.01 103.52 15.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.814 179.717 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.454 ' CB ' ' CG2' ' A' ' 54' ' ' VAL . 3.6 tt -92.54 150.51 20.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.895 -179.721 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 98.9 m -137.13 128.41 28.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.914 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.489 HG23 ' CE2' ' A' ' 38' ' ' TRP . 0.7 OUTLIER -103.91 134.72 44.39 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 CA-C-O 120.821 0.343 . . . . 0.0 110.559 -179.848 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -135.3 163.64 29.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.779 179.754 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' THR . . . . . 0.435 ' CG2' ' HG2' ' A' ' 46' ' ' MET . 0.0 OUTLIER -54.42 106.37 0.2 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.001 -179.923 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 53.29 46.69 25.9 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.029 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 8.6 t -175.33 115.07 0.15 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.904 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -112.55 116.32 30.04 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.19 -179.741 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 53.9 m-20 -119.3 125.85 50.07 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.527 179.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.475 ' N ' ' CD2' ' A' ' 133' ' ' LEU . 0.1 OUTLIER -104.32 162.49 13.17 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.027 -179.049 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 1.2 mtt -138.97 111.96 7.91 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.789 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.429 ' HA ' ' CG2' ' A' ' 122' ' ' ILE . . . -55.41 107.27 0.31 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.696 179.243 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -87.47 -23.31 24.49 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.269 -179.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -100.57 -35.53 9.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.753 179.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -75.68 -19.57 59.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.277 179.779 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 72.91 62.65 0.1 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.021 0.439 . . . . 0.0 110.76 -179.35 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -177.28 -170.05 0.27 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.464 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 21.1 mt -118.62 141.94 35.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.976 0.417 . . . . 0.0 111.364 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . 0.416 HG21 ' CD1' ' A' ' 133' ' ' LEU . 5.7 mt -109.49 131.33 60.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.93 179.765 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -115.05 162.12 17.43 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.427 -179.196 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -152.32 119.81 6.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.618 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 30.4 m80 -129.34 54.96 1.78 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.228 -179.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -99.0 -46.96 5.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.655 179.361 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' MET . . . . . . . . . . . . . 2.8 mmt -151.87 -173.87 4.67 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.506 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 7.9 mm100 -47.4 -64.32 0.81 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.857 0.36 . . . . 0.0 111.081 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 3.3 p 171.6 -53.98 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.823 179.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -150.39 -178.97 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.056 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 11.2 t -168.78 -67.64 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.951 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -126.46 119.64 27.72 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.972 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -99.66 -171.32 2.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.981 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -95.02 -33.06 12.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.907 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 81.46 -67.69 3.59 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.591 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 61.55 164.69 0.3 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.391 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -170.55 58.05 0.28 Allowed Pre-proline 0 C--N 1.329 -0.31 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -95.57 170.17 15.5 Favored 'Cis proline' 0 N--CA 1.459 -0.541 0 C-N-CA 124.244 -1.149 . . . . 0.0 112.59 1.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -65.84 -39.0 90.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.768 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 179.45 67.75 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.655 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . 67.04 -70.88 0.1 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.941 -179.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -148.14 45.71 1.07 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.792 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -123.57 158.29 31.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.039 -179.656 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.422 HG11 ' N ' ' A' ' 165' ' ' ALA . 72.1 t -136.54 141.26 41.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.539 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . 0.422 ' N ' HG11 ' A' ' 164' ' ' VAL . . . -123.3 148.69 45.7 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.964 0.411 . . . . 0.0 111.5 -179.5 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -122.6 152.73 40.14 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.787 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 15.0 p -95.6 146.27 7.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.917 0.389 . . . . 0.0 111.236 -179.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -139.16 106.55 5.54 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.024 -179.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 18.0 mttt -85.28 97.5 9.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.045 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.406 ' N ' ' O ' ' A' ' 171' ' ' PRO . 7.6 p-10 -177.69 95.57 0.23 Allowed Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.842 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . 0.406 ' O ' ' N ' ' A' ' 170' ' ' ASP . 31.8 Cg_exo -59.48 163.92 27.86 Favored 'Cis proline' 0 C--N 1.349 0.599 0 C-N-CA 123.611 -1.412 . . . . 0.0 112.389 0.51 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . 0.402 ' O ' ' CB ' ' A' ' 173' ' ' ASN . 2.6 t -67.11 168.17 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.829 179.805 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . 0.402 ' CB ' ' O ' ' A' ' 172' ' ' VAL . 1.6 t-20 78.45 49.14 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.007 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 52.97 103.48 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.111 179.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 3.1 mmp_? -133.25 -61.57 0.82 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.029 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -113.15 155.07 25.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.179 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' CYS . . . . . . . . . . . . . 1.2 m -135.92 108.59 7.48 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.815 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 20.2 m170 -67.08 163.24 20.48 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.476 179.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . 0.434 HG23 ' N ' ' A' ' 180' ' ' LEU . 35.7 mm -123.51 149.24 27.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 120.703 0.287 . . . . 0.0 110.741 179.609 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.434 ' N ' HG23 ' A' ' 179' ' ' ILE . 0.4 OUTLIER -144.4 165.54 27.65 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.942 -179.811 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -152.28 113.36 4.23 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.934 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' CYS . . . . . . . . . . . . . 42.7 t -126.73 129.69 24.01 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.942 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -75.96 -27.9 8.12 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.427 2.085 . . . . 0.0 112.171 179.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -178.86 156.19 0.82 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.77 179.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 106.43 -88.45 0.55 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.429 -179.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . 0.495 ' HB2' ' CD1' ' A' ' 52' ' ' TYR . 2.7 tp -80.75 -24.26 38.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.741 0.305 . . . . 0.0 110.932 179.711 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' ALA . . . . . 0.447 ' HA ' ' CG2' ' A' ' 190' ' ' VAL . . . -50.56 -25.75 4.47 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.098 179.805 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 63.4 mm-40 -72.0 -40.62 68.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.377 -179.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . 0.416 ' CB ' ' NE1' ' A' ' 38' ' ' TRP . 2.2 m-20 -79.79 -54.46 5.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.165 -179.276 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . 0.447 ' CG2' ' HA ' ' A' ' 187' ' ' ALA . 19.8 m -50.78 -49.35 26.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.069 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . 0.418 ' CG2' ' O ' ' A' ' 187' ' ' ALA . 2.9 tt -55.7 -20.78 8.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.238 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 74.36 103.59 0.07 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.802 0.334 . . . . 0.0 111.047 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 4.5 m -166.47 -52.75 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.049 179.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 6.6 pt -100.78 108.55 23.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.421 -179.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 46.41 -167.29 0.06 OUTLIER Glycine 0 C--N 1.33 0.2 0 C-N-CA 121.054 -0.593 . . . . 0.0 112.983 179.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 175.5 134.02 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.785 0.326 . . . . 0.0 110.814 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -57.35 102.61 0.09 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.899 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' PHE . . . . . 0.422 ' O ' ' CB ' ' A' ' 199' ' ' GLU . 1.1 t80 -83.1 -157.0 0.21 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.985 -179.675 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . 0.422 ' CB ' ' O ' ' A' ' 198' ' ' PHE . 0.3 OUTLIER 80.49 49.75 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.944 0.402 . . . . 0.0 110.818 -179.589 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 179.06 106.42 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.694 179.555 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 11.9 ttm-85 -136.11 71.52 1.42 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.208 -179.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 62.23 15.16 7.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.677 179.258 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.77 -34.96 4.64 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.858 0.361 . . . . 0.0 110.716 179.508 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 52.92 173.96 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.087 179.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 53.08 22.74 2.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.263 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 14.8 tp 49.57 25.61 1.47 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.093 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 4.9 mmp_? . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.241 -0.885 . . . . 0.0 110.916 179.948 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.21 0 N-CA-C 112.447 -0.261 . . . . 0.0 112.447 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.455 ' O ' HD22 ' A' ' 19' ' ' LEU . 19.9 mt-30 63.13 158.06 0.07 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.753 0.311 . . . . 0.0 110.892 -179.845 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.455 HD22 ' O ' ' A' ' 18' ' ' GLN . 1.0 OUTLIER -130.13 115.42 17.02 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.922 -179.994 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 89.93 162.22 38.15 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.368 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -143.87 -177.18 18.56 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.57 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -166.7 37.04 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.754 0.311 . . . . 0.0 110.925 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -106.33 27.93 8.24 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.968 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -102.99 163.82 11.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.897 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -152.59 60.52 0.81 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.005 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -131.95 28.48 4.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.851 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 13.7 m-70 -100.88 165.29 11.42 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.979 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -75.32 -179.61 44.4 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.497 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -86.52 -163.47 0.9 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.764 0.316 . . . . 0.0 110.906 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -72.27 172.74 9.74 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.982 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.57 HG23 ' H ' ' A' ' 32' ' ' ASN . 2.2 m -49.61 -58.82 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.346 -179.488 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.57 ' H ' HG23 ' A' ' 31' ' ' VAL . 5.3 p-10 170.1 66.19 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.809 0.338 . . . . 0.0 110.875 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.2 mttm -149.48 137.51 11.75 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.907 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -78.25 170.48 18.53 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.587 2.191 . . . . 0.0 112.386 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.6 t -168.32 167.84 11.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.948 179.784 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -141.97 128.93 20.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.978 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -123.72 -142.64 6.09 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.345 179.673 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' TRP . . . . . 0.609 ' CE2' HG21 ' A' ' 126' ' ' VAL . 17.0 t-105 -62.83 136.76 58.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.735 0.302 . . . . 0.0 111.005 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.503 HD13 ' OH ' ' A' ' 52' ' ' TYR . 3.2 tp 67.88 -62.45 0.35 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.751 -179.503 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' HIS . . . . . 0.563 ' CB ' ' HD3' ' A' ' 41' ' ' PRO . 30.8 m80 -151.71 -81.87 0.01 OUTLIER Pre-proline 0 CA--C 1.539 0.555 0 CA-C-O 119.202 -0.427 . . . . 0.0 111.511 179.128 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.563 ' HD3' ' CB ' ' A' ' 40' ' ' HIS . 23.3 Cg_endo -89.3 -175.76 1.18 Allowed 'Trans proline' 0 C--N 1.359 1.102 0 C-N-CA 121.58 1.52 . . . . 0.0 112.356 179.435 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.425 ' O ' ' CG2' ' A' ' 45' ' ' VAL . 1.1 m-20 -90.67 -36.55 14.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.366 177.87 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.428 ' O ' ' HD2' ' A' ' 48' ' ' PRO . 0.3 OUTLIER -62.31 -25.54 67.93 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.258 -179.698 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.45 ' HB2' ' HG2' ' A' ' 41' ' ' PRO . 2.1 tppm? -59.52 -27.89 66.58 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.339 -179.232 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.426 ' CG2' HG23 ' A' ' 128' ' ' THR . 1.1 m -95.58 -40.0 10.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.691 0.281 . . . . 0.0 111.454 179.339 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' MET . . . . . 0.534 ' HG2' HG21 ' A' ' 128' ' ' THR . 14.6 mtm -78.15 0.98 22.8 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -178.522 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -132.32 -74.25 0.1 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.032 -1.08 . . . . 0.0 113.24 -179.131 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.428 ' HD2' ' O ' ' A' ' 43' ' ' ASP . 88.0 Cg_endo -85.29 -35.72 0.15 Allowed 'Trans proline' 0 N--CA 1.462 -0.327 0 C-N-CA 122.899 2.399 . . . . 0.0 113.22 -177.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.423 ' N ' ' O ' ' A' ' 44' ' ' LYS . . . 73.32 138.86 0.37 Allowed Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.123 -178.685 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 1.048 HG22 HG22 ' A' ' 126' ' ' VAL . 3.8 m -81.97 114.14 22.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.777 0.323 . . . . 0.0 110.817 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.407 ' HB3' ' OG1' ' A' ' 125' ' ' THR . 91.3 p -128.58 130.12 46.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.029 0.442 . . . . 0.0 111.824 -178.502 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.503 ' OH ' HD13 ' A' ' 39' ' ' LEU . 0.3 OUTLIER -152.01 178.37 9.51 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.124 178.606 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 8.4 mt -88.18 106.87 18.48 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.067 0.46 . . . . 0.0 110.759 179.709 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.722 HG12 ' HB2' ' A' ' 182' ' ' CYS . 0.2 OUTLIER -126.57 136.25 61.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.713 179.872 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.36 113.69 20.31 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.084 0.469 . . . . 0.0 110.912 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 45.0 t80 -74.65 116.95 15.93 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.374 179.1 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.489 ' HB2' HG22 ' A' ' 179' ' ' ILE . 34.0 mmm -103.1 146.06 28.96 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.412 -178.752 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -43.17 170.46 0.01 OUTLIER Glycine 0 C--N 1.331 0.301 0 CA-C-N 115.624 -0.716 . . . . 0.0 113.51 -178.782 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 13.7 m -98.01 164.52 12.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.837 0.351 . . . . 0.0 111.038 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.719 HG12 ' OG ' ' A' ' 113' ' ' SER . 33.0 m -123.46 116.77 49.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.06 -179.613 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.429 ' CB ' ' O ' ' A' ' 112' ' ' ARG . 16.9 tp10 -77.4 116.99 18.45 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.774 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.516 ' C ' HD22 ' A' ' 63' ' ' LEU . 6.7 t -108.38 147.47 13.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.268 -179.627 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.516 HD22 ' C ' ' A' ' 62' ' ' VAL . 3.7 mm? -114.47 -24.71 8.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.13 -179.629 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -45.25 161.39 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.479 -179.543 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -172.97 -68.42 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.806 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 1.7 mtt -113.07 -67.63 0.99 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.719 179.677 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 34.7 ttm-85 -67.07 82.42 0.12 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.774 179.618 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -124.66 -163.15 1.14 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.317 -179.454 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.586 ' C ' HD23 ' A' ' 69' ' ' LEU . 8.1 tt -49.67 -67.75 0.23 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.93 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.506 ' CB ' HD23 ' A' ' 69' ' ' LEU . 25.9 t0 -171.29 84.48 0.08 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.761 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 51.75 24.92 2.64 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.893 -179.637 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 16.5 p30 -174.27 151.31 1.61 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.099 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.8 HG21 HG21 ' A' ' 109' ' ' ILE . 0.0 OUTLIER -168.95 31.24 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.868 179.856 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 2.0 mtp85 -67.17 -65.02 0.74 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.16 -179.504 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.424 ' OG1' ' N ' ' A' ' 76' ' ' GLN . 0.6 OUTLIER -59.55 -59.9 4.7 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.984 0.421 . . . . 0.0 110.078 179.819 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.493 ' CB ' ' CB ' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -41.63 -67.74 0.23 Allowed 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.359 -179.214 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.86 ' HA ' HD11 ' A' ' 110' ' ' LEU . 86.8 t -51.13 -69.87 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.462 -178.917 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.528 HG22 HD11 ' A' ' 82' ' ' ILE . 3.4 m -41.6 -29.59 0.18 Allowed 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.754 -178.743 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 40.9 ttt180 -64.36 -59.11 4.75 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.411 -0.358 . . . . 0.0 110.623 179.132 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.466 ' HB2' ' CD ' ' A' ' 105' ' ' PRO . 2.8 tt0 -65.32 -33.76 76.74 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.87 179.755 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.685 ' HB1' HG11 ' A' ' 60' ' ' VAL . . . -58.64 -59.75 4.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.922 179.732 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.788 HD13 ' OG1' ' A' ' 160' ' ' THR . 20.7 mt -50.8 -46.86 29.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.754 179.517 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -62.76 -27.59 69.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.385 178.842 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.41 ' HB3' ' OG ' ' A' ' 113' ' ' SER . 0.1 OUTLIER -66.41 -61.12 2.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.789 179.61 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.612 ' O ' HG12 ' A' ' 89' ' ' VAL . 3.9 p -48.87 -38.5 10.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.824 179.42 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -67.59 -36.88 81.71 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.793 179.475 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.537 ' OE2' HG21 ' A' ' 96' ' ' THR . 3.1 tp10 -56.3 -47.67 78.23 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.744 179.774 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -67.44 -42.91 82.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.059 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.612 HG12 ' O ' ' A' ' 85' ' ' VAL . 7.4 p -119.12 78.81 17.78 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.862 179.695 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -69.76 -9.87 27.16 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.681 2.254 . . . . 0.0 112.823 -179.559 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -48.48 -36.95 18.49 Favored Glycine 0 C--N 1.331 0.3 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.554 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -68.25 -36.16 79.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.793 0.33 . . . . 0.0 111.101 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 56.98 102.72 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.843 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -147.35 -45.57 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.725 -179.767 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -123.74 -44.17 2.1 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.734 0.302 . . . . 0.0 111.245 -179.535 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.537 HG21 ' OE2' ' A' ' 87' ' ' GLU . 12.2 t -125.48 -164.92 1.35 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.053 -179.685 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -168.66 140.46 2.69 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.878 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 9.2 mmm180 61.47 -82.65 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.849 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -168.3 129.49 1.34 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.85 179.66 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -179.59 93.23 0.2 Allowed Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.977 -179.377 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -67.52 143.77 64.25 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.587 2.191 . . . . 0.0 112.374 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 20.2 m -126.87 159.86 32.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.017 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 11.6 t -75.56 -177.05 3.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.009 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 13.9 mmm180 60.65 152.6 0.1 OUTLIER Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.901 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.592 ' HG2' HD11 ' A' ' 109' ' ' ILE . 60.7 Cg_endo -72.03 -178.01 19.16 Favored 'Cis proline' 0 C--N 1.35 0.627 0 C-N-CA 123.83 -1.321 . . . . 0.0 113.015 0.8 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.545 ' O ' HD12 ' A' ' 109' ' ' ILE . 17.1 tp -80.41 157.86 26.14 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.34 -179.109 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.63 ' O ' HD13 ' A' ' 109' ' ' ILE . 0.1 OUTLIER 74.83 170.72 0.28 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.097 179.687 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 47.1 t -85.44 88.09 7.47 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.048 -179.686 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.8 HG21 HG21 ' A' ' 73' ' ' THR . 0.2 OUTLIER -125.27 160.31 31.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.054 179.639 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.86 HD11 ' HA ' ' A' ' 77' ' ' VAL . 1.7 mp 64.06 157.93 0.08 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.341 179.408 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -133.83 -51.98 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.35 0 CA-C-N 115.916 -0.583 . . . . 0.0 112.075 179.22 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ARG . . . . . 0.429 ' O ' ' CB ' ' A' ' 61' ' ' GLU . 5.3 tmm_? -179.98 138.59 0.12 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.86 0.362 . . . . 0.0 110.915 179.219 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' SER . . . . . 0.719 ' OG ' HG12 ' A' ' 60' ' ' VAL . 50.4 m -105.1 140.48 38.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.167 -179.655 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -101.88 133.78 46.12 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.022 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.796 ' O ' HD22 ' A' ' 115' ' ' LEU . 0.0 OUTLIER -80.24 4.87 16.22 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.955 -0.566 . . . . 0.0 112.074 -179.462 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -42.06 99.73 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 120.811 0.338 . . . . 0.0 111.499 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 70.95 54.04 0.25 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.69 -179.221 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.48 ' HB1' HG11 ' A' ' 89' ' ' VAL . . . -104.82 157.66 17.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.329 -179.565 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 53.74 37.02 56.26 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.919 -0.657 . . . . 0.0 112.65 179.633 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -106.97 116.71 58.12 Favored Pre-proline 0 C--N 1.329 -0.31 0 O-C-N 122.932 -0.157 . . . . 0.0 110.58 179.469 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -85.58 109.26 1.1 Allowed 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 122.362 2.041 . . . . 0.0 112.339 178.801 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.653 ' HA ' ' HB3' ' A' ' 136' ' ' ALA . 2.4 pp -135.91 173.5 13.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.964 179.661 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -94.01 103.52 15.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.814 179.717 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.454 ' CB ' ' CG2' ' A' ' 54' ' ' VAL . 3.6 tt -92.54 150.51 20.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.895 -179.721 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.407 ' OG1' ' HB3' ' A' ' 51' ' ' SER . 98.9 m -137.13 128.41 28.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.914 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 1.048 HG22 HG22 ' A' ' 50' ' ' VAL . 0.7 OUTLIER -103.91 134.72 44.39 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 CA-C-O 120.821 0.343 . . . . 0.0 110.559 -179.848 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -135.3 163.64 29.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.779 179.754 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' THR . . . . . 0.534 HG21 ' HG2' ' A' ' 46' ' ' MET . 0.0 OUTLIER -54.42 106.37 0.2 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.001 -179.923 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 53.29 46.69 25.9 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.029 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 8.6 t -175.33 115.07 0.15 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.904 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -112.55 116.32 30.04 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.19 -179.741 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 53.9 m-20 -119.3 125.85 50.07 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.527 179.21 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.707 HD23 ' N ' ' A' ' 133' ' ' LEU . 0.1 OUTLIER -104.32 162.49 13.17 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.027 -179.049 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 134' ' ' MET . . . . . 0.409 ' O ' ' HB ' ' A' ' 122' ' ' ILE . 1.2 mtt -138.97 111.96 7.91 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.789 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.441 ' HA ' ' CG2' ' A' ' 122' ' ' ILE . . . -55.41 107.27 0.31 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.696 179.243 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.653 ' HB3' ' HA ' ' A' ' 122' ' ' ILE . . . -87.47 -23.31 24.49 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.269 -179.531 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -100.57 -35.53 9.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.753 179.552 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -75.68 -19.57 59.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.277 179.779 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 72.91 62.65 0.1 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.021 0.439 . . . . 0.0 110.76 -179.35 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -177.28 -170.05 0.27 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.464 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.403 ' HA ' ' HA ' ' A' ' 134' ' ' MET . 21.1 mt -118.62 141.94 35.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.976 0.417 . . . . 0.0 111.364 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.586 HG21 HD12 ' A' ' 133' ' ' LEU . 5.7 mt -109.49 131.33 60.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.93 179.765 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -115.05 162.12 17.43 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.427 -179.196 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -152.32 119.81 6.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.618 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 30.4 m80 -129.34 54.96 1.78 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.228 -179.362 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -99.0 -46.96 5.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.655 179.361 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' MET . . . . . . . . . . . . . 2.8 mmt -151.87 -173.87 4.67 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.506 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' GLN . . . . . 0.437 ' HG3' ' HG3' ' A' ' 204' ' ' GLN . 7.9 mm100 -47.4 -64.32 0.81 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.857 0.36 . . . . 0.0 111.081 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 3.3 p 171.6 -53.98 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.823 179.806 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -150.39 -178.97 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.056 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 11.2 t -168.78 -67.64 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.951 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -126.46 119.64 27.72 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.972 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -99.66 -171.32 2.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.981 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -95.02 -33.06 12.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.907 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 81.46 -67.69 3.59 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.591 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 61.55 164.69 0.3 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.391 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -170.55 58.05 0.28 Allowed Pre-proline 0 C--N 1.329 -0.31 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -95.57 170.17 15.5 Favored 'Cis proline' 0 N--CA 1.459 -0.541 0 C-N-CA 124.244 -1.149 . . . . 0.0 112.59 1.756 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -65.84 -39.0 90.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.768 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' THR . . . . . 0.788 ' OG1' HD13 ' A' ' 82' ' ' ILE . 0.0 OUTLIER 179.45 67.75 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.655 179.909 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 161' ' ' ALA . . . . . 0.404 ' HB3' ' O ' ' A' ' 160' ' ' THR . . . 67.04 -70.88 0.1 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.941 -179.666 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -148.14 45.71 1.07 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.792 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -123.57 158.29 31.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.039 -179.656 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 72.1 t -136.54 141.26 41.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.539 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -123.3 148.69 45.7 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.964 0.411 . . . . 0.0 111.5 -179.5 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -122.6 152.73 40.14 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.787 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 15.0 p -95.6 146.27 7.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.917 0.389 . . . . 0.0 111.236 -179.585 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.456 ' CB ' ' CE1' ' A' ' 178' ' ' HIS . . . -139.16 106.55 5.54 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.024 -179.827 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 18.0 mttt -85.28 97.5 9.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.045 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.406 ' N ' ' O ' ' A' ' 171' ' ' PRO . 7.6 p-10 -177.69 95.57 0.23 Allowed Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.842 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 171' ' ' PRO . . . . . 0.406 ' O ' ' N ' ' A' ' 170' ' ' ASP . 31.8 Cg_exo -59.48 163.92 27.86 Favored 'Cis proline' 0 C--N 1.349 0.599 0 C-N-CA 123.611 -1.412 . . . . 0.0 112.389 0.51 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.532 HG12 ' H ' ' A' ' 173' ' ' ASN . 2.6 t -67.11 168.17 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.829 179.805 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 173' ' ' ASN . . . . . 0.532 ' H ' HG12 ' A' ' 172' ' ' VAL . 1.6 t-20 78.45 49.14 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.007 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 52.97 103.48 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.111 179.532 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 3.1 mmp_? -133.25 -61.57 0.82 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.029 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -113.15 155.07 25.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.179 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 177' ' ' CYS . . . . . 0.695 ' O ' HG22 ' A' ' 60' ' ' VAL . 1.2 m -135.92 108.59 7.48 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.815 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 178' ' ' HIS . . . . . 0.456 ' CE1' ' CB ' ' A' ' 168' ' ' ALA . 0.8 OUTLIER -67.08 163.24 20.48 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.476 179.309 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 179' ' ' ILE . . . . . 0.489 HG22 ' HB2' ' A' ' 57' ' ' MET . 35.7 mm -123.51 149.24 27.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 120.703 0.287 . . . . 0.0 110.741 179.609 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -144.4 165.54 27.65 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.942 -179.811 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -152.28 113.36 4.23 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.934 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 182' ' ' CYS . . . . . 0.722 ' HB2' HG12 ' A' ' 54' ' ' VAL . 42.7 t -126.73 129.69 24.01 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.942 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -75.96 -27.9 8.12 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.427 2.085 . . . . 0.0 112.171 179.648 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -178.86 156.19 0.82 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.77 179.771 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 106.43 -88.45 0.55 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.429 -179.84 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 186' ' ' LEU . . . . . 0.542 ' HG ' HG13 ' A' ' 190' ' ' VAL . 2.7 tp -80.75 -24.26 38.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.741 0.305 . . . . 0.0 110.932 179.711 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 187' ' ' ALA . . . . . 0.593 ' HB2' ' HB3' ' A' ' 182' ' ' CYS . . . -50.56 -25.75 4.47 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.098 179.805 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 63.4 mm-40 -72.0 -40.62 68.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.377 -179.36 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 189' ' ' ASP . . . . . 0.416 ' CB ' ' NE1' ' A' ' 38' ' ' TRP . 2.2 m-20 -79.79 -54.46 5.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.165 -179.276 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 190' ' ' VAL . . . . . 0.542 HG13 ' HG ' ' A' ' 186' ' ' LEU . 19.8 m -50.78 -49.35 26.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.069 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.534 HG22 ' O ' ' A' ' 187' ' ' ALA . 2.9 tt -55.7 -20.78 8.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.238 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 74.36 103.59 0.07 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.802 0.334 . . . . 0.0 111.047 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 4.5 m -166.47 -52.75 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.049 179.688 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 6.6 pt -100.78 108.55 23.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.421 -179.554 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 46.41 -167.29 0.06 OUTLIER Glycine 0 C--N 1.33 0.2 0 C-N-CA 121.054 -0.593 . . . . 0.0 112.983 179.254 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 175.5 134.02 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.785 0.326 . . . . 0.0 110.814 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 197' ' ' ALA . . . . . 0.57 ' HB2' ' HB2' ' A' ' 38' ' ' TRP . . . -57.35 102.61 0.09 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.899 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 198' ' ' PHE . . . . . 0.422 ' O ' ' CB ' ' A' ' 199' ' ' GLU . 1.1 t80 -83.1 -157.0 0.21 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.985 -179.675 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 199' ' ' GLU . . . . . 0.424 ' HG3' HD13 ' A' ' 206' ' ' LEU . 0.3 OUTLIER 80.49 49.75 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.944 0.402 . . . . 0.0 110.818 -179.589 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 179.06 106.42 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.694 179.555 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 11.9 ttm-85 -136.11 71.52 1.42 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.208 -179.598 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 62.23 15.16 7.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.677 179.258 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.77 -34.96 4.64 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.858 0.361 . . . . 0.0 110.716 179.508 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 204' ' ' GLN . . . . . 0.437 ' HG3' ' HG3' ' A' ' 148' ' ' GLN . 3.2 mp0 52.92 173.96 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.087 179.491 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 53.08 22.74 2.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.263 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.424 HD13 ' HG3' ' A' ' 199' ' ' GLU . 14.8 tp 49.57 25.61 1.47 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.093 179.836 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 4.9 mmp_? . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.241 -0.885 . . . . 0.0 110.916 179.948 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.21 0 N-CA-C 112.447 -0.261 . . . . 0.0 112.447 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.455 ' O ' HD22 ' A' ' 19' ' ' LEU . 19.9 mt-30 63.13 158.06 0.07 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.753 0.311 . . . . 0.0 110.892 -179.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.455 HD22 ' O ' ' A' ' 18' ' ' GLN . 1.0 OUTLIER -130.13 115.42 17.02 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.922 -179.994 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 89.93 162.22 38.15 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.368 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -143.87 -177.18 18.56 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.57 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -166.7 37.04 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.754 0.311 . . . . 0.0 110.925 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -106.33 27.93 8.24 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.968 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -102.99 163.82 11.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.897 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -152.59 60.52 0.81 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.005 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -131.95 28.48 4.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.851 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 13.7 m-70 -100.88 165.29 11.42 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.979 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -75.32 -179.61 44.4 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.497 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -86.52 -163.47 0.9 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.764 0.316 . . . . 0.0 110.906 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -72.27 172.74 9.74 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.982 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.57 HG23 ' H ' ' A' ' 32' ' ' ASN . 2.2 m -49.61 -58.82 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.346 -179.488 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.57 ' H ' HG23 ' A' ' 31' ' ' VAL . 5.3 p-10 170.1 66.19 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.809 0.338 . . . . 0.0 110.875 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.2 mttm -149.48 137.51 11.75 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.907 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -78.25 170.48 18.53 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.587 2.191 . . . . 0.0 112.386 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.6 t -168.32 167.84 11.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.948 179.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -141.97 128.93 20.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.978 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -123.72 -142.64 6.09 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.345 179.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . 0.609 ' CE2' HG21 ' A' ' 126' ' ' VAL . 17.0 t-105 -62.83 136.76 58.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.735 0.302 . . . . 0.0 111.005 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.503 HD13 ' OH ' ' A' ' 52' ' ' TYR . 3.2 tp 67.88 -62.45 0.35 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.751 -179.503 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . 0.563 ' CB ' ' HD3' ' A' ' 41' ' ' PRO . 36.5 m-70 -151.71 -81.87 0.01 OUTLIER Pre-proline 0 CA--C 1.539 0.555 0 CA-C-O 119.202 -0.427 . . . . 0.0 111.511 179.128 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.563 ' HD3' ' CB ' ' A' ' 40' ' ' HIS . 23.3 Cg_endo -89.3 -175.76 1.18 Allowed 'Trans proline' 0 C--N 1.359 1.102 0 C-N-CA 121.58 1.52 . . . . 0.0 112.356 179.435 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.425 ' O ' ' CG2' ' A' ' 45' ' ' VAL . 1.1 m-20 -90.67 -36.55 14.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.366 177.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.428 ' O ' ' HD2' ' A' ' 48' ' ' PRO . 0.3 OUTLIER -62.31 -25.54 67.93 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.258 -179.698 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.45 ' HB2' ' HG2' ' A' ' 41' ' ' PRO . 2.1 tppm? -59.52 -27.89 66.58 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.339 -179.232 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.426 ' CG2' HG23 ' A' ' 128' ' ' THR . 1.1 m -95.58 -40.0 10.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.691 0.281 . . . . 0.0 111.454 179.339 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . 0.534 ' HG2' HG21 ' A' ' 128' ' ' THR . 14.6 mtm -78.15 0.98 22.8 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -178.522 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -132.32 -74.25 0.1 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.032 -1.08 . . . . 0.0 113.24 -179.131 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.428 ' HD2' ' O ' ' A' ' 43' ' ' ASP . 88.0 Cg_endo -85.29 -35.72 0.15 Allowed 'Trans proline' 0 N--CA 1.462 -0.327 0 C-N-CA 122.899 2.399 . . . . 0.0 113.22 -177.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.423 ' N ' ' O ' ' A' ' 44' ' ' LYS . . . 73.32 138.86 0.37 Allowed Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.123 -178.685 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 1.048 HG22 HG22 ' A' ' 126' ' ' VAL . 3.8 m -81.97 114.14 22.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.777 0.323 . . . . 0.0 110.817 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.407 ' HB3' ' OG1' ' A' ' 125' ' ' THR . 91.3 p -128.58 130.12 46.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.029 0.442 . . . . 0.0 111.824 -178.502 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.503 ' OH ' HD13 ' A' ' 39' ' ' LEU . 0.3 OUTLIER -152.01 178.37 9.51 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.124 178.606 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 8.4 mt -88.18 106.87 18.48 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.067 0.46 . . . . 0.0 110.759 179.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.722 HG12 ' HB2' ' A' ' 182' ' ' CYS . 0.2 OUTLIER -126.57 136.25 61.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.713 179.872 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.36 113.69 20.31 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.084 0.469 . . . . 0.0 110.912 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 45.0 t80 -74.65 116.95 15.93 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.374 179.1 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.489 ' HB2' HG22 ' A' ' 179' ' ' ILE . 34.0 mmm -103.1 146.06 28.96 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.412 -178.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -43.17 170.46 0.01 OUTLIER Glycine 0 C--N 1.331 0.301 0 CA-C-N 115.624 -0.716 . . . . 0.0 113.51 -178.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 13.7 m -98.01 164.52 12.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.837 0.351 . . . . 0.0 111.038 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.719 HG12 ' OG ' ' A' ' 113' ' ' SER . 33.0 m -123.46 116.77 49.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.06 -179.613 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.429 ' CB ' ' O ' ' A' ' 112' ' ' ARG . 16.9 tp10 -77.4 116.99 18.45 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.774 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.516 ' C ' HD22 ' A' ' 63' ' ' LEU . 6.7 t -108.38 147.47 13.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.268 -179.627 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.516 HD22 ' C ' ' A' ' 62' ' ' VAL . 3.7 mm? -114.47 -24.71 8.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.13 -179.629 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -45.25 161.39 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.479 -179.543 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -172.97 -68.42 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.806 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 1.7 mtt -113.07 -67.63 0.99 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.719 179.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 34.7 ttm-85 -67.07 82.42 0.12 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.774 179.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -124.66 -163.15 1.14 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.317 -179.454 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.586 ' C ' HD23 ' A' ' 69' ' ' LEU . 8.1 tt -49.67 -67.75 0.23 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.93 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.506 ' CB ' HD23 ' A' ' 69' ' ' LEU . 25.9 t0 -171.29 84.48 0.08 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.761 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 51.75 24.92 2.64 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.893 -179.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 16.5 p30 -174.27 151.31 1.61 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.099 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.8 HG21 HG21 ' A' ' 109' ' ' ILE . 0.0 OUTLIER -168.95 31.24 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.868 179.856 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 2.0 mtp85 -67.17 -65.02 0.74 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.16 -179.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.424 ' OG1' ' N ' ' A' ' 76' ' ' GLN . 0.6 OUTLIER -59.55 -59.9 4.7 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.984 0.421 . . . . 0.0 110.078 179.819 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.493 ' CB ' ' CB ' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -41.63 -67.74 0.23 Allowed 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.359 -179.214 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.86 ' HA ' HD11 ' A' ' 110' ' ' LEU . 86.8 t -51.13 -69.87 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.462 -178.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.528 HG22 HD11 ' A' ' 82' ' ' ILE . 3.4 m -41.6 -29.59 0.18 Allowed 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.754 -178.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 40.9 ttt180 -64.36 -59.11 4.75 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.411 -0.358 . . . . 0.0 110.623 179.132 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.466 ' HB2' ' CD ' ' A' ' 105' ' ' PRO . 2.8 tt0 -65.32 -33.76 76.74 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.87 179.755 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.685 ' HB1' HG11 ' A' ' 60' ' ' VAL . . . -58.64 -59.75 4.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.922 179.732 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.788 HD13 ' OG1' ' A' ' 160' ' ' THR . 20.7 mt -50.8 -46.86 29.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.754 179.517 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -62.76 -27.59 69.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.385 178.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.41 ' HB3' ' OG ' ' A' ' 113' ' ' SER . 0.1 OUTLIER -66.41 -61.12 2.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.789 179.61 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.612 ' O ' HG12 ' A' ' 89' ' ' VAL . 3.9 p -48.87 -38.5 10.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.824 179.42 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -67.59 -36.88 81.71 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.793 179.475 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.537 ' OE2' HG21 ' A' ' 96' ' ' THR . 3.1 tp10 -56.3 -47.67 78.23 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.744 179.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -67.44 -42.91 82.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.059 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.612 HG12 ' O ' ' A' ' 85' ' ' VAL . 7.4 p -119.12 78.81 17.78 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.862 179.695 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -69.76 -9.87 27.16 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.681 2.254 . . . . 0.0 112.823 -179.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -48.48 -36.95 18.49 Favored Glycine 0 C--N 1.331 0.3 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.554 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -68.25 -36.16 79.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.793 0.33 . . . . 0.0 111.101 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 56.98 102.72 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.843 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -147.35 -45.57 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.725 -179.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -123.74 -44.17 2.1 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.734 0.302 . . . . 0.0 111.245 -179.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.537 HG21 ' OE2' ' A' ' 87' ' ' GLU . 12.2 t -125.48 -164.92 1.35 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.053 -179.685 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -168.66 140.46 2.69 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.878 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 9.2 mmm180 61.47 -82.65 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.849 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -168.3 129.49 1.34 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.85 179.66 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -179.59 93.23 0.2 Allowed Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.977 -179.377 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -67.52 143.77 64.25 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.587 2.191 . . . . 0.0 112.374 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 20.2 m -126.87 159.86 32.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.017 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 11.6 t -75.56 -177.05 3.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.009 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 13.9 mmm180 60.65 152.6 0.1 OUTLIER Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.901 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.592 ' HG2' HD11 ' A' ' 109' ' ' ILE . 60.7 Cg_endo -72.03 -178.01 19.16 Favored 'Cis proline' 0 C--N 1.35 0.627 0 C-N-CA 123.83 -1.321 . . . . 0.0 113.015 0.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.545 ' O ' HD12 ' A' ' 109' ' ' ILE . 17.1 tp -80.41 157.86 26.14 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.34 -179.109 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.63 ' O ' HD13 ' A' ' 109' ' ' ILE . 0.1 OUTLIER 74.83 170.72 0.28 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.097 179.687 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 47.1 t -85.44 88.09 7.47 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.048 -179.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.8 HG21 HG21 ' A' ' 73' ' ' THR . 0.2 OUTLIER -125.27 160.31 31.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.054 179.639 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.86 HD11 ' HA ' ' A' ' 77' ' ' VAL . 1.7 mp 64.06 157.93 0.08 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.341 179.408 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -133.83 -51.98 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.35 0 CA-C-N 115.916 -0.583 . . . . 0.0 112.075 179.22 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . 0.429 ' O ' ' CB ' ' A' ' 61' ' ' GLU . 5.3 tmm_? -179.98 138.59 0.12 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.86 0.362 . . . . 0.0 110.915 179.219 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . 0.719 ' OG ' HG12 ' A' ' 60' ' ' VAL . 50.4 m -105.1 140.48 38.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.167 -179.655 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -101.88 133.78 46.12 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.022 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.796 ' O ' HD22 ' A' ' 115' ' ' LEU . 0.0 OUTLIER -80.24 4.87 16.22 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.955 -0.566 . . . . 0.0 112.074 -179.462 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -42.06 99.73 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 120.811 0.338 . . . . 0.0 111.499 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 70.95 54.04 0.25 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.69 -179.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.48 ' HB1' HG11 ' A' ' 89' ' ' VAL . . . -104.82 157.66 17.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.329 -179.565 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 53.74 37.02 56.26 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.919 -0.657 . . . . 0.0 112.65 179.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -106.97 116.71 58.12 Favored Pre-proline 0 C--N 1.329 -0.31 0 O-C-N 122.932 -0.157 . . . . 0.0 110.58 179.469 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -85.58 109.26 1.1 Allowed 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 122.362 2.041 . . . . 0.0 112.339 178.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.653 ' HA ' ' HB3' ' A' ' 136' ' ' ALA . 2.4 pp -135.91 173.5 13.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.964 179.661 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -94.01 103.52 15.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.814 179.717 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.454 ' CB ' ' CG2' ' A' ' 54' ' ' VAL . 3.6 tt -92.54 150.51 20.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.895 -179.721 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.407 ' OG1' ' HB3' ' A' ' 51' ' ' SER . 98.9 m -137.13 128.41 28.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.914 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 1.048 HG22 HG22 ' A' ' 50' ' ' VAL . 0.7 OUTLIER -103.91 134.72 44.39 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 CA-C-O 120.821 0.343 . . . . 0.0 110.559 -179.848 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -135.3 163.64 29.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.779 179.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . 0.534 HG21 ' HG2' ' A' ' 46' ' ' MET . 0.0 OUTLIER -54.42 106.37 0.2 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.001 -179.923 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 53.29 46.69 25.9 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.029 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 8.6 t -175.33 115.07 0.15 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.904 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -112.55 116.32 30.04 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.19 -179.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 53.9 m-20 -119.3 125.85 50.07 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.527 179.21 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.707 HD23 ' N ' ' A' ' 133' ' ' LEU . 0.1 OUTLIER -104.32 162.49 13.17 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.027 -179.049 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . 0.409 ' O ' ' HB ' ' A' ' 122' ' ' ILE . 1.2 mtt -138.97 111.96 7.91 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.789 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.441 ' HA ' ' CG2' ' A' ' 122' ' ' ILE . . . -55.41 107.27 0.31 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.696 179.243 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.653 ' HB3' ' HA ' ' A' ' 122' ' ' ILE . . . -87.47 -23.31 24.49 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.269 -179.531 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -100.57 -35.53 9.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.753 179.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -75.68 -19.57 59.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.277 179.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 72.91 62.65 0.1 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.021 0.439 . . . . 0.0 110.76 -179.35 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -177.28 -170.05 0.27 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.464 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.403 ' HA ' ' HA ' ' A' ' 134' ' ' MET . 21.1 mt -118.62 141.94 35.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.976 0.417 . . . . 0.0 111.364 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.586 HG21 HD12 ' A' ' 133' ' ' LEU . 5.7 mt -109.49 131.33 60.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.93 179.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -115.05 162.12 17.43 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.427 -179.196 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -152.32 119.81 6.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.618 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 30.4 m80 -129.34 54.96 1.78 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.228 -179.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -99.0 -46.96 5.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.655 179.361 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' MET . . . . . . . . . . . . . 2.8 mmt -151.87 -173.87 4.67 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.506 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . 0.437 ' HG3' ' HG3' ' A' ' 204' ' ' GLN . 7.9 mm100 -47.4 -64.32 0.81 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.857 0.36 . . . . 0.0 111.081 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 3.3 p 171.6 -53.98 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.823 179.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -150.39 -178.97 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.056 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 11.2 t -168.78 -67.64 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.951 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -126.46 119.64 27.72 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.972 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -99.66 -171.32 2.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.981 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -95.02 -33.06 12.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.907 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 81.46 -67.69 3.59 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.591 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 61.55 164.69 0.3 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.391 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -170.55 58.05 0.28 Allowed Pre-proline 0 C--N 1.329 -0.31 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -95.57 170.17 15.5 Favored 'Cis proline' 0 N--CA 1.459 -0.541 0 C-N-CA 124.244 -1.149 . . . . 0.0 112.59 1.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -65.84 -39.0 90.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.768 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . 0.788 ' OG1' HD13 ' A' ' 82' ' ' ILE . 0.0 OUTLIER 179.45 67.75 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.655 179.909 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . 0.404 ' HB3' ' O ' ' A' ' 160' ' ' THR . . . 67.04 -70.88 0.1 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.941 -179.666 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -148.14 45.71 1.07 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.792 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -123.57 158.29 31.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.039 -179.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 72.1 t -136.54 141.26 41.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.539 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -123.3 148.69 45.7 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.964 0.411 . . . . 0.0 111.5 -179.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -122.6 152.73 40.14 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.787 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 15.0 p -95.6 146.27 7.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.917 0.389 . . . . 0.0 111.236 -179.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.501 ' HB2' ' CD2' ' A' ' 178' ' ' HIS . . . -139.16 106.55 5.54 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.024 -179.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 18.0 mttt -85.28 97.5 9.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.045 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.406 ' N ' ' O ' ' A' ' 171' ' ' PRO . 7.6 p-10 -177.69 95.57 0.23 Allowed Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.842 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . 0.406 ' O ' ' N ' ' A' ' 170' ' ' ASP . 31.8 Cg_exo -59.48 163.92 27.86 Favored 'Cis proline' 0 C--N 1.349 0.599 0 C-N-CA 123.611 -1.412 . . . . 0.0 112.389 0.51 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.532 HG12 ' H ' ' A' ' 173' ' ' ASN . 2.6 t -67.11 168.17 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.829 179.805 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . 0.532 ' H ' HG12 ' A' ' 172' ' ' VAL . 1.6 t-20 78.45 49.14 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.007 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 52.97 103.48 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.111 179.532 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 3.1 mmp_? -133.25 -61.57 0.82 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.029 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -113.15 155.07 25.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.179 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' CYS . . . . . 0.695 ' O ' HG22 ' A' ' 60' ' ' VAL . 1.2 m -135.92 108.59 7.48 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.815 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' HIS . . . . . 0.501 ' CD2' ' HB2' ' A' ' 168' ' ' ALA . 20.2 m170 -67.08 163.24 20.48 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.476 179.309 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . 0.489 HG22 ' HB2' ' A' ' 57' ' ' MET . 35.7 mm -123.51 149.24 27.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 120.703 0.287 . . . . 0.0 110.741 179.609 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -144.4 165.54 27.65 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.942 -179.811 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -152.28 113.36 4.23 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.934 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' CYS . . . . . 0.722 ' HB2' HG12 ' A' ' 54' ' ' VAL . 42.7 t -126.73 129.69 24.01 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.942 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -75.96 -27.9 8.12 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.427 2.085 . . . . 0.0 112.171 179.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -178.86 156.19 0.82 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.77 179.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 106.43 -88.45 0.55 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.429 -179.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . 0.542 ' HG ' HG13 ' A' ' 190' ' ' VAL . 2.7 tp -80.75 -24.26 38.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.741 0.305 . . . . 0.0 110.932 179.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' ALA . . . . . 0.593 ' HB2' ' HB3' ' A' ' 182' ' ' CYS . . . -50.56 -25.75 4.47 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.098 179.805 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 63.4 mm-40 -72.0 -40.62 68.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.377 -179.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . 0.416 ' CB ' ' NE1' ' A' ' 38' ' ' TRP . 2.2 m-20 -79.79 -54.46 5.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.165 -179.276 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . 0.542 HG13 ' HG ' ' A' ' 186' ' ' LEU . 19.8 m -50.78 -49.35 26.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.069 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.534 HG22 ' O ' ' A' ' 187' ' ' ALA . 2.9 tt -55.7 -20.78 8.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.238 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 74.36 103.59 0.07 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.802 0.334 . . . . 0.0 111.047 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 4.5 m -166.47 -52.75 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.049 179.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 6.6 pt -100.78 108.55 23.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.421 -179.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 46.41 -167.29 0.06 OUTLIER Glycine 0 C--N 1.33 0.2 0 C-N-CA 121.054 -0.593 . . . . 0.0 112.983 179.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 175.5 134.02 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.785 0.326 . . . . 0.0 110.814 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' ALA . . . . . 0.57 ' HB2' ' HB2' ' A' ' 38' ' ' TRP . . . -57.35 102.61 0.09 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.899 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' PHE . . . . . 0.422 ' O ' ' CB ' ' A' ' 199' ' ' GLU . 1.1 t80 -83.1 -157.0 0.21 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.985 -179.675 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . 0.424 ' HG3' HD13 ' A' ' 206' ' ' LEU . 0.3 OUTLIER 80.49 49.75 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.944 0.402 . . . . 0.0 110.818 -179.589 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 179.06 106.42 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.694 179.555 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 11.9 ttm-85 -136.11 71.52 1.42 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.208 -179.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 62.23 15.16 7.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.677 179.258 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.77 -34.96 4.64 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.858 0.361 . . . . 0.0 110.716 179.508 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' GLN . . . . . 0.437 ' HG3' ' HG3' ' A' ' 148' ' ' GLN . 3.2 mp0 52.92 173.96 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.087 179.491 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 53.08 22.74 2.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.263 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.424 HD13 ' HG3' ' A' ' 199' ' ' GLU . 14.8 tp 49.57 25.61 1.47 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.093 179.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 4.9 mmp_? . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.241 -0.885 . . . . 0.0 110.916 179.948 . . . . . . . . 0 0 . 1 stop_ save_